{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:04:43Z","timestamp":1792854283115,"version":"4.5.0"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270031"],"award-info":[{"award-number":["81270031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372375"],"award-info":[{"award-number":["81372375"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773044"],"award-info":[{"award-number":["81773044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272737"],"award-info":[{"award-number":["81272737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473278"],"award-info":[{"award-number":["81473278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cellimm.2019.104008","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T11:20:17Z","timestamp":1572866417000},"page":"104008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["B7-H4, a promising target for immunotherapy"],"prefix":"10.1016","volume":"347","author":[{"given":"Jia-Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2019.104008_b0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.iy.07.040189.002305","article-title":"Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy","volume":"7","author":"Mueller","year":"1989","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.19.1.225","article-title":"Complexities of CD28\/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation","volume":"19","author":"Salomon","year":"2001","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1615\/CritRevImmunol.v18.i5.10","article-title":"CD28\/B7 costimulation: a review","volume":"18","author":"Greenfield","year":"1998","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.immunol.19.1.565","article-title":"CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy","volume":"19","author":"Chambers","year":"2001","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0030","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2019.104008_b0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0040","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/70932","article-title":"B7\u2013H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion","volume":"5","author":"Dong","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2019.104008_b0045","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.193.7.839","article-title":"B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells","volume":"193","author":"Tseng","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2019.104008_b0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1471-4906(01)01888-9","article-title":"PD-1: an inhibitory immunoreceptor involved in peripheral tolerance","volume":"22","author":"Nishimura","year":"2001","journal-title":"Trend. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"THE B7 family revisited","volume":"23","author":"Greenwald","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0060","doi-asserted-by":"crossref","unstructured":"M. Janakiram, U.A. Shah, W. Liu, A. Zhao, M.P. Schoenberg, X. Zang, The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3, 276, 2017, 26\u201339.","DOI":"10.1111\/imr.12521"},{"key":"10.1016\/j.cellimm.2019.104008_b0065","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(03)00152-3","article-title":"B7\u2013H4, a molecule of the B7 family, negatively regulates T cell immunity","volume":"18","author":"Sica","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2019.104008_b0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.it.2003.08.005","article-title":"BTLA: a new inhibitory receptor with a B7-like ligand","volume":"24","author":"Carreno","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0075","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.171.9.4650","article-title":"Genomic organization and expression analysis of B7\u2013H4, an immune inhibitory molecule of the B7 family","volume":"171","author":"Choi","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0080","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.micinf.2004.03.007","article-title":"Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses","volume":"6","author":"Wang","year":"2004","journal-title":"Microb. Infect."},{"key":"10.1016\/j.cellimm.2019.104008_b0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/gb-2005-6-6-223","article-title":"The B7 family of immune-regulatory ligands","volume":"6","author":"Collins","year":"2005","journal-title":"Geno. Biol."},{"key":"10.1016\/j.cellimm.2019.104008_b0090","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.it.2013.07.003","article-title":"B7 family checkpoint regulators in immune regulation and disease","volume":"34","author":"Ceeraz","year":"2013","journal-title":"Trend. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0095","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/1535-7163.MCT-16-0761","article-title":"New B7 Family Checkpoints in Human Cancers","volume":"16","author":"Ni","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellimm.2019.104008_b0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.12530","article-title":"Potential targeting of B7\u2013H4 for the treatment of cancer","volume":"276","author":"Podojil","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2019.104008_b0105","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1073\/pnas.1434299100","article-title":"B7x: a widely expressed B7 family member that inhibits T cell activation","volume":"100","author":"Zang","year":"2003","journal-title":"Proceed. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2019.104008_b0110","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1074-7613(03)00147-X","article-title":"B7S1, a novel B7 family member that negatively regulates T cell activation","volume":"18","author":"Prasad","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2019.104008_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-9-394","article-title":"B7\u2013H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population","volume":"9","author":"Zhang","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellimm.2019.104008_b0120","first-page":"412","article-title":"The Immune regulator vtcn1 gene polymorphisms and its impact on susceptibility to","volume":"29","author":"Tsai","year":"2015","journal-title":"Breast Cancer"},{"key":"10.1016\/j.cellimm.2019.104008_b0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3906\/sag-1603-54","article-title":"Association of B7\u2013H4 gene polymorphisms in urothelial bladder cancer","volume":"47","author":"Ozgoz","year":"2017","journal-title":"Turkish J. Med. Sci."},{"key":"10.1016\/j.cellimm.2019.104008_b0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cellimm.2014.11.006","article-title":"Five functional polymorphisms of B7\/CD28 co-signaling molecules alter susceptibility to colorectal cancer","volume":"293","author":"Wu","year":"2015","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0135","first-page":"2193","article-title":"<em>CD226<\/em> (<em>DNAM-1<\/em>) is associated with susceptibility to juvenile idiopathic","volume":"74","author":"Reinards","year":"2015","journal-title":"Arthritis"},{"key":"10.1016\/j.cellimm.2019.104008_b0140","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1136\/annrheumdis-2013-205138","article-title":"CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritis","volume":"74","author":"Reinards","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellimm.2019.104008_b0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/annrheumdis-2011-200574","article-title":"Novel genetic association of the VTCN1 region with rheumatoid arthritis","volume":"71","author":"Daha","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellimm.2019.104008_b0150","doi-asserted-by":"crossref","unstructured":"H.M. Albers, T.H.C.M. Reinards, D.M.C. Brinkman, S.S.M. Kamphuis, M.A.J. van Rossum, E.P.H. Hoppenreijs, H.J. Girschick, C. Wouters, R.K. Saurenmann, E. Bakker, W. Verduijn, P. Slagboom, T.W.J. Huizinga, R.E.M. Toes, J.J. Houwing-Duistermaat, R. ten Cate, M.W. Schilham, Genetic variation in <em>VTCN1<\/em> (B7-H4) is associated with course of disease in juvenile idiopathic arthritis, 73 (2014) 1198-1201.","DOI":"10.1136\/annrheumdis-2013-204466"},{"key":"10.1016\/j.cellimm.2019.104008_b0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03009742.2016.1238959","article-title":"Non-HLA gene polymorphisms in juvenile idiopathic arthritis: associations with disease outcome","volume":"46","author":"Alberdi-Saugstrup","year":"2017","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.cellimm.2019.104008_b0160","first-page":"1842","article-title":"B7\u2013H4 Is highly expressed in ductal and lobular","volume":"11","author":"Tringler","year":"2005","journal-title":"Breast Cancer"},{"key":"10.1016\/j.cellimm.2019.104008_b0165","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yexcr.2005.01.018","article-title":"The immunomodulatory protein B7\u2013H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation","volume":"306","author":"Salceda","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cellimm.2019.104008_b0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.gene.2017.04.003","article-title":"Clinical significance of the B7\u2013H4 as a novel prognostic marker in breast cancer","volume":"623","author":"Huang","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.cellimm.2019.104008_b0175","first-page":"184","article-title":"B7\u2013H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor","volume":"3","author":"Rahbar","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2019.104008_b0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2005.08.060","article-title":"B7\u2013H4 overexpression in ovarian tumors","volume":"100","author":"Tringler","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cellimm.2019.104008_b0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2006.03.056","article-title":"Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy","volume":"103","author":"Bignotti","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cellimm.2019.104008_b0190","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ygyno.2007.03.035","article-title":"B7\u2013H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression","volume":"106","author":"Simon","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cellimm.2019.104008_b0195","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-04-3550","article-title":"B7\u2013h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer","volume":"66","author":"Simon","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2019.104008_b0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5732\/cjc.009.10158","article-title":"Expressions of osteopontin and B7\u2013H4 in epithelial ovarian neoplasm and their significance","volume":"29","author":"Zhang","year":"2010","journal-title":"Chinese J. Cancer"},{"key":"10.1016\/j.cellimm.2019.104008_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.06.011","article-title":"B7\u2013H4 expression in ovarian serous carcinoma: a study of 306 cases","volume":"57","author":"Liang","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.cellimm.2019.104008_b0210","first-page":"957","article-title":"A biomarker panel increases the diagnostic performance for epithelial ovarian cancer Type I and II in young women","volume":"36","author":"Leandersson","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cellimm.2019.104008_b0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygyno.2007.03.039","article-title":"B7\u2013H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration","volume":"106","author":"Miyatake","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cellimm.2019.104008_b0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3892\/mco.2013.225","article-title":"B7\u2013H4 overexpression correlates with a poor prognosis for cervical cancer patients","volume":"2","author":"Liu","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.cellimm.2019.104008_b0225","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3892\/or.2016.4607","article-title":"B7\u2013H3, B7\u2013H4, Foxp3 and IL-2 expression in cervical cancer: associations with patient outcome and clinical significance","volume":"35","author":"Huang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellimm.2019.104008_b0230","first-page":"345","article-title":"[Expression of B7\u2013H4 in prostate cancer and its clinical significance], Zhejiang da xue xue bao. Yi xue ban","volume":"39","author":"Qian","year":"2010","journal-title":"J. Zheji. Univer. Med. Sci."},{"key":"10.1016\/j.cellimm.2019.104008_b0235","doi-asserted-by":"crossref","first-page":"19458","DOI":"10.1073\/pnas.0709802104","article-title":"B7\u2013H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome","volume":"104","author":"Zang","year":"2007","journal-title":"Proceed. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2019.104008_b0240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lungcan.2006.05.012","article-title":"B7\u2013H3 and B7\u2013H4 expression in non-small-cell lung cancer","volume":"53","author":"Sun","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cellimm.2019.104008_b0245","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1073\/pnas.0600937103","article-title":"B7\u2013H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival","volume":"103","author":"Krambeck","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.cellimm.2019.104008_b0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4111\/kju.2011.52.2.90","article-title":"The Relationship between B7\u2013H4 Expression and Clinicopathological Characteristics in Clinical Stage T1 Conventional Renal Cell Carcinoma","volume":"52","author":"Jung","year":"2011","journal-title":"Korean J. Urol."},{"key":"10.1016\/j.cellimm.2019.104008_b0255","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1038\/onc.2012.600","article-title":"The costimulatory molecule B7\u2013H4 promote tumor progression and cell proliferation through translocating into nucleus","volume":"32","author":"Zhang","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cellimm.2019.104008_b0260","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3892\/mmr.2016.5510","article-title":"B7\u2013H4 expression in human infiltrating ductal carcinomaassociated macrophages","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellimm.2019.104008_b0265","first-page":"6768","article-title":"B7\u2013H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma","volume":"7","author":"Fan","year":"2014","journal-title":"Int. J. Clin. Exp. Path."},{"key":"10.1016\/j.cellimm.2019.104008_b0270","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.7314\/APJCP.2013.14.5.3011","article-title":"B7\u2013H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer","volume":"14","author":"Zhu","year":"2013","journal-title":"Asian Pac. J. Cancer Prevent. APJCP"},{"key":"10.1016\/j.cellimm.2019.104008_b0275","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2147\/OTT.S66809","article-title":"The coexpression and clinical significance of costimulatory molecules B7\u2013H1, B7\u2013H3, and B7\u2013H4 in human pancreatic cancer","volume":"7","author":"Chen","year":"2014","journal-title":"OncoTarg. Therapy"},{"key":"10.1016\/j.cellimm.2019.104008_b0280","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00262-011-1017-3","article-title":"B7\u2013H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma","volume":"60","author":"Chen","year":"2011","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.cellimm.2019.104008_b0285","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/cas.12949","article-title":"B7\u2013H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6\/signal transducer and activator of transcription 3 pathway activation","volume":"107","author":"Chen","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellimm.2019.104008_b0290","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1007\/s13277-015-4132-5","article-title":"Roles of coinhibitory molecules B7\u2013H3 and B7\u2013H4 in esophageal squamous cell carcinoma","volume":"37","author":"Wang","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.cellimm.2019.104008_b0295","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/jso.21722","article-title":"Expression of B7\u2013H4 in blood of patients with gastric cancer predicts tumor progression and prognosis","volume":"102","author":"Arigami","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.cellimm.2019.104008_b0300","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00268-011-1186-4","article-title":"Clinical significance of the B7\u2013H4 coregulatory molecule as a novel prognostic marker in gastric cancer","volume":"35","author":"Arigami","year":"2011","journal-title":"World J. Surg."},{"key":"10.1016\/j.cellimm.2019.104008_b0305","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10147-014-0701-7","article-title":"Expression of costimulatory molecules B7\u2013H1, B7\u2013H4 and Foxp3+ Tregs in gastric cancer and its clinical significance","volume":"20","author":"Geng","year":"2015","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.cellimm.2019.104008_b0310","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12026-011-8227-9","article-title":"T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract","volume":"50","author":"Lu","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cellimm.2019.104008_b0315","first-page":"1","article-title":"Increased B7\u2013H1 and B7\u2013H4 expressions on circulating monocytes and tumor-associated macrophages are involved in immune evasion in patients with gastric cancer","volume":"54","author":"Matsunaga","year":"2011","journal-title":"Yonago Acta Medica"},{"key":"10.1016\/j.cellimm.2019.104008_b0320","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.acthis.2014.06.003","article-title":"B7\u2013H1 and B7\u2013H4 expression in colorectal carcinoma: correlation with tumor FOXP3+ regulatory T-cell infiltration","volume":"116","author":"Zhao","year":"2014","journal-title":"Acta Histochem."},{"key":"10.1016\/j.cellimm.2019.104008_b0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0015-6","article-title":"Upregulation of B7\u2013H4 promotes tumor progression of intrahepatic cholangiocarcinoma","volume":"8","author":"Xie","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellimm.2019.104008_b0330","doi-asserted-by":"crossref","first-page":"80878","DOI":"10.18632\/oncotarget.20718","article-title":"B7\u2013H4 overexpression is essential for early hepatocellular carcinoma progression and recurrence","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2019.104008_b0335","first-page":"1539","article-title":"Expression and subcellular distribution of costimulatory molecules B7\u2013H1, B7\u2013H3 and B7\u2013H4 in human hematologic malignancy cell lines","volume":"24","author":"Zhang","year":"2016","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"10.1016\/j.cellimm.2019.104008_b0340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-008-9601-x","article-title":"B7\u2013H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells","volume":"89","author":"Yao","year":"2008","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.cellimm.2019.104008_b0345","first-page":"180","article-title":"The expressions of co-stimulatory molecules are altered on putative antigen-presenting cells in cord blood","volume":"69","author":"Darmochwal-Kolarz","year":"2013","journal-title":"Am. J. Reprod. Immunol. (New York, N.Y 1989)"},{"key":"10.1016\/j.cellimm.2019.104008_b0350","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1158\/1078-0432.CCR-15-0858","article-title":"B7\u2013H4(B7x)-Mediated cross-talk between glioma-initiating cells and macrophages via the IL6\/JAK\/STAT3 pathway lead to poor prognosis in glioma patients","volume":"22","author":"Yao","year":"2016","journal-title":"Clin. Cancer Res. Off. J. Am. Associat. Cancer Res."},{"key":"10.1016\/j.cellimm.2019.104008_b0355","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10735-012-9475-2","article-title":"Expression and anatomical distribution of TIM-containing molecules in Langerhans cell sarcoma","volume":"44","author":"Li","year":"2013","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.cellimm.2019.104008_b0360","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.acthis.2011.12.010","article-title":"The characteristic expression of B7-associated proteins in Langerhans cell sarcoma","volume":"114","author":"Li","year":"2012","journal-title":"Acta Histochem"},{"key":"10.1016\/j.cellimm.2019.104008_b0365","first-page":"3100","article-title":"B7\u2013H4 expression in human melanoma: its association with patients' survival and antitumor immune","volume":"17","author":"Quandt","year":"2011","journal-title":"Response"},{"key":"10.1016\/j.cellimm.2019.104008_b0370","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10238-010-0125-2","article-title":"B7\u2013H4 expression in various tumors determined using a novel developed monoclonal antibody","volume":"11","author":"Qian","year":"2011","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.cellimm.2019.104008_b0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.imlet.2013.07.009","article-title":"Expression of co-stimulatory molecule B7\u2013H4 in patients suffering from rheumatoid arthritis","volume":"154","author":"Chen","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cellimm.2019.104008_b0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01765","article-title":"Immunosuppressive effect of B7\u2013H4 pathway in a murine systemic lupus erythematosus model","volume":"8","author":"Xiao","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0385","first-page":"611","article-title":"The presence of B7-H4+ macrophages and CD25+CD4+ and FOXP3+ regulatory T cells in the microenvironment of nasal polyps \u2013 a preliminary report","volume":"48","author":"Dutsch-Wicherek","year":"2010","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.cellimm.2019.104008_b0390","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MPA.0b013e31829695d2","article-title":"B7\u2013H4 expression in normal and diseased human islet beta cells","volume":"43","author":"Cheung","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.cellimm.2019.104008_b0395","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/TP.0b013e318277229d","article-title":"Endogenous expression of B7\u2013H4 improves long-term murine islet allograft survival","volume":"95","author":"Wang","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104008_b0400","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.canlet.2008.02.067","article-title":"B7\u2013H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation","volume":"266","author":"Song","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellimm.2019.104008_b0405","doi-asserted-by":"crossref","first-page":"67196","DOI":"10.18632\/oncotarget.11950","article-title":"TGF-\u03b21 promotes colorectal cancer immune escape by elevating B7\u2013H3 and B7\u2013H4 via the miR-155\/miR-143 axis","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2019.104008_b0410","first-page":"278","volume":"2","author":"Darmochwal-Kolarz","year":"2012","journal-title":"Health"},{"key":"10.1016\/j.cellimm.2019.104008_b0415","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jri.2013.04.004","article-title":"The expression of B7\u2013H1 and B7\u2013H4 co-stimulatory molecules on myeloid and plasmacytoid dendritic cells in pre-eclampsia and normal pregnancy","volume":"99","author":"Darmochwal-Kolarz","year":"2013","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0420","first-page":"117","article-title":"Diagnostic value of soluble B7\u2013H4 in malignant pleural effusion","volume":"92","author":"Xu","year":"2012","journal-title":"Zhonghua yi xue za zhi"},{"key":"10.1016\/j.cellimm.2019.104008_b0425","doi-asserted-by":"crossref","unstructured":"X. Jing, F. Wei, J. Li, L. Dai, X. Wang, L. Jia, H. Wang, L. An, Y. Yang, G. Zhang, Z. Cheng, Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion, 12, 2018, 986\u2013990.","DOI":"10.1111\/crj.12615"},{"key":"10.1016\/j.cellimm.2019.104008_b0430","first-page":"842","article-title":"[The Protective Effect of B7\u2013H4 on Concanavalin A Induced Hepatic Injury in Mice], Sichuan da xue xue bao. Yi xue ban","volume":"46","author":"Xiao","year":"2015","journal-title":"J. Sichuan Univers. Med. Sci. Ed."},{"key":"10.1016\/j.cellimm.2019.104008_b0435","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/cam4.754","article-title":"Higher preoperative serum levels of PD-L1 and B7\u2013H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma","volume":"5","author":"Fukuda","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.cellimm.2019.104008_b0440","first-page":"893","article-title":"[Clinical significance of determination of serum B7\u2013H4 in patients with malignant hematologic diseases], Xi bao yu fen zi mian yi xue za zhi","volume":"26","author":"Wang","year":"2010","journal-title":"Chin. J. Cellul. Mol. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0445","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biopha.2015.05.016","article-title":"Effect of VTCN1 on progression and metastasis of ovarian carcinoma in vitro and vivo","volume":"73","author":"Gao","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellimm.2019.104008_b0450","first-page":"699","article-title":"Detection of early-stage extrahepatic cholangiocarcinoma in patients with biliary strictures by soluble B7\u2013H4 in the bile","volume":"8","author":"Ke","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.cellimm.2019.104008_b0455","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.3892\/mmr.2016.5887","article-title":"Aberrant expression of B7\u2013H4 may contribute to the development of hepatocellular carcinoma","volume":"14","author":"Yuan","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellimm.2019.104008_b0460","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbrc.2009.08.144","article-title":"Possible involvement of soluble B7\u2013H4 in T cell-mediated inflammatory immune responses","volume":"389","author":"Kamimura","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellimm.2019.104008_b0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000166","article-title":"Potential role of decoy B7\u2013H4 in the pathogenesis of rheumatoid arthritis: a mouse model informed by clinical data","volume":"6","author":"Azuma","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.cellimm.2019.104008_b0470","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.2337\/db14-0213","article-title":"Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7\u2013H4) marks type 1 diabetes development","volume":"63","author":"Radichev","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.cellimm.2019.104008_b0475","doi-asserted-by":"crossref","unstructured":"P. Mach, A. Gellhaus, L. Wicherek, B. Schmidt, R. Kimmig, S. Kasimir-Bauer, A. Koninger, Changes in the Blood Serum Levels of the Costimulatory Soluble B7-H4 Molecule in Pregnant Women During the Peripartal Phase, American journal of reproductive immunology (New York, N.Y. : 1989), 74, 2015, 209\u2013215.","DOI":"10.1111\/aji.12392"},{"key":"10.1016\/j.cellimm.2019.104008_b0480","doi-asserted-by":"crossref","unstructured":"P. Mach, A. Koninger, L. Wicherek, R. Kimmig, S. Kasimir-Bauer, C. Birdir, B. Schmidt, A. Gellhaus, Serum concentrations of soluble B7-H4 in early pregnancy are elevated in women with preterm premature rupture of fetal membranes, American journal of reproductive immunology (New York, N.Y. : 1989), 76, 2016, 149\u2013154.","DOI":"10.1111\/aji.12527"},{"key":"10.1016\/j.cellimm.2019.104008_b0485","doi-asserted-by":"crossref","unstructured":"P. Mach, L. Nolte-Boenigk, L. Droste, L. Fox, M. Frank, B. Schmidt, F. Herse, S. Verlohren, L. Wicherek, A. Iannaccone, C. Birdir, D. Andrikos, R. Kimmig, A. Gellhaus, A. Koninger, Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia, American journal of reproductive immunology (New York, N.Y. : 1989), 80, 2018, e12988.","DOI":"10.1111\/aji.12988"},{"key":"10.1016\/j.cellimm.2019.104008_b0490","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20050930","article-title":"B7\u2013H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma","volume":"203","author":"Kryczek","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2019.104008_b0495","doi-asserted-by":"crossref","unstructured":"I. Kryczek, S. Wei, G. Zhu, L. Myers, P. Mottram, P. Cheng, L. Chen, G. Coukos, W. Zou, Relationship between B7-H4, Regulatory T Cells, and Patient Outcome in Human Ovarian Carcinoma, 67, 2007, 8900\u20138905.","DOI":"10.1158\/0008-5472.CAN-07-1866"},{"key":"10.1016\/j.cellimm.2019.104008_b0500","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1681\/ASN.2009060592","article-title":"IL-10\/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis","volume":"21","author":"Cao","year":"2010","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"10.1016\/j.cellimm.2019.104008_b0505","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3892\/ol.2014.1961","article-title":"B7\u2013H4 expression and its role in interleukin-2\/interferon treatment of clear cell renal cell carcinoma","volume":"7","author":"Xu","year":"2014","journal-title":"Oncol. Lett."},{"issue":"2012","key":"10.1016\/j.cellimm.2019.104008_b0510","first-page":"3054","article-title":"Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection","volume":"189","author":"Hofmeyer","year":"1950","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"key":"10.1016\/j.cellimm.2019.104008_b0515","doi-asserted-by":"crossref","first-page":"82740","DOI":"10.18632\/oncotarget.21098","article-title":"Tumor-expressed immune checkpoint B7x promotes cancer progression and antigen-specific CD8 T cell exhaustion and suppressive innate immune cells","volume":"8","author":"Ohaegbulam","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2019.104008_b0520","first-page":"689","article-title":"[The effects of B7H4 on human bone marrow mesenchymal stem cell inhibiting proliferation of PHA activated T cells], Zhonghua xue ye xue za zhi","volume":"30","author":"Luan","year":"2009","journal-title":"Zhonghua xueyexue zazhi"},{"key":"10.1016\/j.cellimm.2019.104008_b0525","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3727\/000000006783981837","article-title":"Suppression of human T-cell responses to beta-cells by activation of B7\u2013H4 pathway","volume":"15","author":"Ou","year":"2006","journal-title":"Cell Transplant."},{"key":"10.1016\/j.cellimm.2019.104008_b0530","first-page":"1041","article-title":"Control of effector CD8<sup>+<\/sup> T Cell function by the transcription","volume":"302","author":"Pearce","year":"2003","journal-title":"Factor <em>Eomesodermin<\/em>"},{"key":"10.1016\/j.cellimm.2019.104008_b0535","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/scd.2009.0076","article-title":"The negative co-signaling molecule b7\u2013h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity","volume":"19","author":"Xue","year":"2010","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.cellimm.2019.104008_b0540","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1229620","article-title":"Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection","volume":"338","author":"Paley","year":"2012","journal-title":"Science (New York, N.Y.),"},{"key":"10.1016\/j.cellimm.2019.104008_b0545","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2019.104008_b0550","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.immuni.2018.03.018","article-title":"Co-inhibitory molecule B7 superfamily member 1 expressed by tumor-infiltrating myeloid cells induces dysfunction of anti-tumor CD8+ T Cells","volume":"48","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2019.104008_b0555","article-title":"B7\u2013H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2019.104008_b0560","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cei.12452","article-title":"B7x\/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis","volume":"179","author":"Pawar","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0565","doi-asserted-by":"crossref","first-page":"58563","DOI":"10.18632\/oncotarget.10542","article-title":"Nuclear localization of B7\u2013H4 in pulmonary adenocarcinomas presenting as a solitary pulmonary nodule","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2019.104008_b0570","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbrc.2015.02.098","article-title":"Cancer cell-associated cytoplasmic B7\u2013H4 is induced by hypoxia through hypoxia-inducible factor-1\u03b1 and promotes cancer cell proliferation","volume":"459","author":"Jeon","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2013","key":"10.1016\/j.cellimm.2019.104008_b0575","first-page":"3806","article-title":"Host b7x promotes pulmonary metastasis of breast cancer","volume":"190","author":"Abadi","year":"1950","journal-title":"Journal of immunology (Baltimore Md.:1950)"},{"key":"10.1016\/j.cellimm.2019.104008_b0580","doi-asserted-by":"crossref","first-page":"72242","DOI":"10.18632\/oncotarget.12665","article-title":"Prognostic significance of B7\u2013H4 expression in matched primary pancreatic cancer and liver metastases","volume":"7","author":"Qian","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2019.104008_b0585","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2147\/OTT.S48085","article-title":"Clinical significance of B7\u2013H4 expression in matched non-small cell lung cancer brain metastases and primary tumors","volume":"6","author":"Li","year":"2013","journal-title":"OncoTarget. Ther."},{"key":"10.1016\/j.cellimm.2019.104008_b0590","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3892\/or.2017.5481","article-title":"Roles of immune inhibitory molecule B7\u2013H4 in cervical cancer","volume":"37","author":"Han","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellimm.2019.104008_b0595","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/IGC.0b013e3181ad0fa2","article-title":"B7\u2013H4 expression promotes tumorigenesis in ovarian cancer","volume":"19","author":"Cheng","year":"2009","journal-title":"Int. J. Gynecol. Cancer: Off. J. Int. Gynecol. Cancer Society"},{"key":"10.1016\/j.cellimm.2019.104008_b0600","doi-asserted-by":"crossref","first-page":"92227","DOI":"10.18632\/oncotarget.21152","article-title":"The tissue distribution and significance of B7\u2013H4 in laryngeal carcinoma","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2019.104008_b0605","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3727\/096504018X15172227703244","article-title":"B7-homolog 4 promotes epithelial-mesenchymal transition and invasion of bladder cancer cells via activation of nuclear factor-kappaB","volume":"26","author":"Wu","year":"2018","journal-title":"Oncol. Res."},{"key":"10.1016\/j.cellimm.2019.104008_b0610","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/15321819.2011.578190","article-title":"Overexpression of B7\u2013H4 in tumor infiltrated dendritic cells","volume":"32","author":"Cheng","year":"2011","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.cellimm.2019.104008_b0615","first-page":"797","article-title":"[Effect of ShRNA targeting silencing of VTCN1 gene on nasopharyngeal carcinoma cells], Lin chuang er bi yan hou tou jing wai ke za zhi","volume":"31","author":"Dong","year":"2017","journal-title":"J. Clin. Otorhinolaryngol. Head Neck Surg."},{"key":"10.1016\/j.cellimm.2019.104008_b0620","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.4049\/jimmunol.1201241","article-title":"X. Zang, B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells","volume":"189","author":"Lee","year":"1950","journal-title":"J. Immunol. (Baltimore, Md.:1950)"},{"key":"10.1016\/j.cellimm.2019.104008_b0625","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1084\/jem.20100639","article-title":"Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity","volume":"208","author":"Wei","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2019.104008_b0630","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3727\/096368911X582750","article-title":"B7\u2013H4 induces donor-specific tolerance in mouse islet allografts","volume":"21","author":"Wang","year":"2012","journal-title":"Cell Transplant."},{"key":"10.1016\/j.cellimm.2019.104008_b0635","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.trim.2009.03.007","article-title":"B7\u2013H4 transfection prolongs \u03b2-cell graft survival","volume":"21","author":"Yuan","year":"2009","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0640","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s10753-010-9280-6","article-title":"Intracellular B7\u2013H4 suppresses bile duct epithelial cell apoptosis in human primary biliary cirrhosis","volume":"34","author":"Chen","year":"2011","journal-title":"Inflammation"},{"key":"10.1016\/j.cellimm.2019.104008_b0645","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.4049\/jimmunol.1001322","article-title":"Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity","volume":"186","author":"Papenfuss","year":"2011","journal-title":"J. Immunol. (Baltimore Md.:1950)"},{"key":"10.1016\/j.cellimm.2019.104008_b0650","first-page":"898","article-title":"Identification of genes differentially expressed in menstrual breakdown and repair","volume":"22","author":"Paiva","year":"2016","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.cellimm.2019.104008_b0655","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ni1144","article-title":"B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator","volume":"6","author":"Sedy","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0660","article-title":"B7\u2013H4 is a positive regulator of antitumor immunity","volume":"5","author":"Rahbar","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cellimm.2019.104008_b0665","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20010659","article-title":"Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression","volume":"195","author":"Devadas","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2019.104008_b0670","first-page":"1267","article-title":"Silencing of B7\u2013H4 suppresses the tumorigenicity of the MGC-803 human gastric cancer cell line and promotes cell apoptosis via the mitochondrial signaling pathway","volume":"52","author":"Zhou","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cellimm.2019.104008_b0675","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00424-014-1493-3","article-title":"B7\u2013H4 downregulation induces mitochondrial dysfunction and enhances doxorubicin sensitivity via the cAMP\/CREB\/PGC1-\u03b1 signaling pathway in HeLa cells","volume":"466","author":"Kim","year":"2014","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"key":"10.1016\/j.cellimm.2019.104008_b0680","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yexcr.2018.08.014","article-title":"Negative roles of B7\u2013H3 and B7\u2013H4 in the microenvironment of cervical cancer","volume":"371","author":"Han","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cellimm.2019.104008_b0685","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2567.2009.03111.x","article-title":"Cell cycle arrest induced by engagement of B7\u2013H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines","volume":"128","author":"Park","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2019.104008_b0690","first-page":"1121","article-title":"[Inhibition of PI3K\/AKT signaling pathway promotes the nuclear translocation of B7\u2013H4], Xi bao yu fen zi mian yi xue za zhi","volume":"30","author":"Song","year":"2014","journal-title":"Chin. J. Cell. Molecul. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0695","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/leu.2017.232","article-title":"B7\u2013H4 enhances the differentiation of murine leukemia-initiating cells via the PTEN\/AKT\/RCOR2\/RUNX1 pathways","volume":"31","author":"Xia","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.cellimm.2019.104008_b0700","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4049\/jimmunol.1700811","article-title":"B7\u2013H4 modulates regulatory CD4(+) T cell induction and function via ligation of a Semaphorin 3a\/Plexin A4\/Neuropilin-1 Complex","volume":"201","author":"Podojil","year":"2018","journal-title":"J. Immunol. (Baltimore Md.:1950)"},{"key":"10.1016\/j.cellimm.2019.104008_b0705","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-018-0597-9","article-title":"B7\u2013H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer","volume":"18","author":"Wang","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cellimm.2019.104008_b0710","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/326981","article-title":"Role of B7\u2013H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line","volume":"2015","author":"Peng","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.cellimm.2019.104008_b0715","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00262-017-1961-7","article-title":"Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10","volume":"66","author":"Che","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2019.104008_b0720","doi-asserted-by":"crossref","DOI":"10.1038\/srep44485","article-title":"Human immunodeficiency virus Type-1 myeloid derived suppressor cells inhibit cytomegalovirus inflammation through interleukin-27 and B7\u2013H4","volume":"7","author":"Garg","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2019.104008_b0725","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1435250","article-title":"NF-kappaB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8(+) T cells for tumor promotion","volume":"7","author":"Li","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cellimm.2019.104008_b0730","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4049\/jimmunol.1403251","article-title":"Loss of peripheral protection in pancreatic islets by proteolysis-driven impairment of VTCN1 (B7\u2013H4) presentation is associated with the development of autoimmune diabetes","volume":"196","author":"Radichev","year":"2016","journal-title":"J. Immunol. (Baltimore Md.:1950)"},{"key":"10.1016\/j.cellimm.2019.104008_b0735","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1159\/000485086","article-title":"MicroRNA expression profiling of pancreatic cancer cell Line L3.6p1 following B7\u2013H4 knockdown","volume":"44","author":"Qian","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cellimm.2019.104008_b0740","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bbrc.2017.07.135","article-title":"MicroRNA-125b-5p modulates the inflammatory state of macrophages via targeting B7\u2013H4","volume":"491","author":"Diao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellimm.2019.104008_b0745","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3892\/mmr.2016.4757","article-title":"Downregulation of B7\u2013H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide","volume":"13","author":"Cui","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellimm.2019.104008_b0750","first-page":"437","article-title":"[Sunitinib inhibits the expressions of co-stimulatory molecule ligands on dendritic cells], Xi bao yu fen zi mian yi xue za zhi","volume":"32","author":"Ding","year":"2016","journal-title":"Chin. J. Cell. Molecu. Immunol."},{"key":"10.1016\/j.cellimm.2019.104008_b0755","doi-asserted-by":"crossref","first-page":"47400","DOI":"10.18632\/oncotarget.17653","article-title":"Immune signature of metastatic breast cancer: Identifying predictive markers of immunotherapy response","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2019.104008_b0760","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.molonc.2016.07.004","article-title":"LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome","volume":"10","author":"Ramirez-Ardila","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cellimm.2019.104008_b0765","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-9-348","article-title":"Deciphering downstream gene targets of PI3K\/mTOR\/p70S6K pathway in breast cancer","volume":"9","author":"Heinonen","year":"2008","journal-title":"BMC Genom."},{"key":"10.1016\/j.cellimm.2019.104008_b0770","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1021\/mp5007745","article-title":"An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancer","volume":"12","author":"Leong","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cellimm.2019.104008_b0775","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/mt.2016.149","article-title":"Tumor regression and delayed onset toxicity following B7\u2013H4 CAR T Cell Therapy","volume":"24","author":"Smith","year":"2016","journal-title":"Mol. Ther. J. Am. Soc. Gene Therap."},{"key":"10.1016\/j.cellimm.2019.104008_b0780","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1158\/1078-0432.CCR-17-3123","article-title":"A T-cell-engaging B7\u2013H4\/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer","volume":"25","author":"Iizuka","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2019.104008_b0785","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2013.04.001","article-title":"B7\u2013H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10\/Treg-dependent mechanisms","volume":"44","author":"Podojil","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2019.104008_b0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199719","article-title":"Serum soluble B7\u2013H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma","volume":"13","author":"Azuma","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2019.104008_b0795","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3892\/ol.2014.2522","article-title":"B7\u2013H4 expression in bladder urothelial carcinoma and immune escape mechanisms","volume":"8","author":"Liu","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cellimm.2019.104008_b0800","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/modpathol.2010.95","article-title":"Tumor associated endothelial expression of B7\u2013H3 predicts survival in ovarian carcinomas","volume":"23","author":"Zang","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cellimm.2019.104008_b0805","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.4049\/jimmunol.1000749","article-title":"T-bet and eomesodermin are required for T cell-mediated antitumor immune responses","volume":"185","author":"Zhu","year":"2010","journal-title":"J. Immunol. (Baltimore Md.:1950)"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874919303168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874919303168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:54:26Z","timestamp":1776171266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874919303168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":161,"alternative-id":["S0008874919303168"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2019.104008","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B7-H4, a promising target for immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2019.104008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104008"}}